Experience

CyberConvoy

• United States
• Computer and Network Security
• 1 - 100 Employee

• Software Engineer/Full Stack Developer

  • Jun 2023 - Present



Docketeer

• United States
• Software Development
• 1 - 100 Employee

• Software Engineer

  • 2022 - Jun 2023

  • Led a team of engineers in the design and development of Docketeer (through a partnership with open source lab), utilizing the latest technologies such as React, RTK, Tailwind, cAdvisor, Prometheus, Grafana, NodeExporter, and Docker • Modularized application to microservice architecture through constructing multi-architecture docker images that comprise the entire application and required dependencies to achieve deployment, development, and management optimizations • Transformed existing client-side code (integration of RTK, custom-hooks, and other abstractions) to eliminate significant technical debt by adhering to MVC design pattern ultimately bolstering longevity by increasing the maintainability of the software • Reconstructed entire UI/UX utilizing TailwindCSS to provide the first major design change since the inception of Docketeer Show less



NYU Bluestone Center for Clinical Research

• United States
• Research Services
• 1 - 100 Employee

• Clinical Researcher

  • 2018 - 2021

  • Contributed in transition to RedCap for research data organization/monitoring • Contributed to innovative clinical research involving identification of novel biomarkers in squamous cell carcinoma to eliminate elective neck dissections in patients • Constructed annual IND report for pharmaceutical company & FDA on phase 2, single-center, single-arm, open-label trial of vismodegib in patients with keratocystic odontogenic tumors • Contributed in transition to RedCap for research data organization/monitoring • Contributed to innovative clinical research involving identification of novel biomarkers in squamous cell carcinoma to eliminate elective neck dissections in patients • Constructed annual IND report for pharmaceutical company & FDA on phase 2, single-center, single-arm, open-label trial of vismodegib in patients with keratocystic odontogenic tumors



New York University - College of Dentistry

• United States
• Higher Education
• 300 - 400 Employee

• Graduate Student Researcher

  • 2017 - 2021

  • Investigating the implications of DOACs in surgical treatment through a multicenter retrospective analysis conducted with surgeons at Univ. of Connecticut to establish a clinical consensus • Exploring physiology & anatomy of the maxillary sinus • Investigating the implications of DOACs in surgical treatment through a multicenter retrospective analysis conducted with surgeons at Univ. of Connecticut to establish a clinical consensus • Exploring physiology & anatomy of the maxillary sinus